investigator_user investigator user funding collaborators pending menu bell message arrow_up arrow_down filter layers globe marker add arrow close download edit facebook info linkedin minus plus save share search sort twitter remove user-plus user-minus
  • Project leads
  • Collaborators

Preclinical Evaluation of Novel Therapeutics for CNS Tumor Therapy

Katherine Warren

1 Collaborator(s)

Funding source

National Cancer Institute (NIH)
Collaborating with SU2C team in evaluating agents for therapeutic intent in children with CNS tumors. Plan to evaluate azacytidine and decitabine in our nonhuman primate model.

Related projects